Abstract: The present disclosure provides a bioreactor for extracting cell-derived products from cultured cells, the bioreactor comprising a container, an inlet for inputting cell culture medium into the container, an outlet for outputting cell culture medium comprising cell-derived products from the container, the container comprising, or being connected to, a compartment comprising nanostructured cellulose configured to receive cells, said compartment comprising a first separating surface separating the nanostructured cellulose from the outlet and allowing cell culture medium comprising cell-derived products to pass through the first separating surface. The present disclosure also provides a method for separating cell-derived products from cultured cells and a nanostructured cellulose product.

Abstract: The present disclosure provides ex vivo tumour immune microenvironment model comprising patient-derived explant with a tumour-specific immune cell profile embedded in a matrix comprising nanofibrillar cellulose hydrogel having a concentration in the range of 0.25-1.2% by weight, wherein the nanofibrillar cellulose comprises fibrils and/or fibril bundles having number-average diameter of 200 nm or less.

Abstract: The present disclosure provides a method for preparing microbeads comprising nanofibrillar cellulose, the method comprising providing a dispersion of chemically anionically modified nanofibrillar cellulose having a number-average diameter of 200 nm or less, forming the nanofibrillar cellulose into microbeads, to obtain microbeads comprising chemically anionically modified nanofibrillar cellulose in the range of 0.2-2% by weight. The present disclosure also provides the microbeads, a cell culture, a method for providing cell-derived products, use of the microbeads and use of chemically anionically modified nanofibrillar cellulose for preparing the microbeads.